publication . Article . 2016

Atypical Distribution of Late Gadolinium Enhancement of the Left Ventricle on Cardiac Magnetic Resonance in Classical Anderson-Fabry Disease

Shusuke Kasuya; Masayo Suzuki; Tsutomu Inaoka; Masayuki Odashima; Tomoya Nakatsuka; Rumiko Ishikawa; Wataru Tokuyama; Hitoshi Terada;
Open Access
  • Published: 29 Jan 2016 Journal: Journal of the Belgian Society of Radiology, volume 100 (eissn: 1780-2393, Copyright policy)
  • Publisher: Ubiquity Press, Ltd.
Anderson-Fabry disease (AFD) is an X-linked lysosomal storage disorder caused by a deficiency of alpha-galactosidase A. Approximately 50% of patients with AFD may have cardiac involvement. Gadolinium-enhanced cardiac magnetic resonance (CMR) is useful for the diagnosis of cardiac involvement of AFD by recognizing typical late gadolinium enhancement (LGE) patterns. We report a 48-year-old man with cardiac involvement in classical AFD, showing atypical distribution of the LGE at the mid-lateral wall of left ventricle, predominantly apical segments without basal involvement on gadolinium-enhanced CMR.
Persistent Identifiers
Medical Subject Headings: cardiovascular systemcardiovascular diseases
free text keywords: Anderson-Fabry disease (AFD); cardiac magnetic resonance (CMR); late gadolinium enhancement (LGE); hypertrophic cardiomyopathy, Case Report, Anderson-Fabry disease (AFD), cardiac magnetic resonance (CMR), late gadolinium enhancement (LGE), Cardiac magnetic resonance, Basal (phylogenetics), Cardiology, medicine.medical_specialty, medicine, Hypertrophic cardiomyopathy, medicine.disease, Anderson-Fabry Disease, Internal medicine, Late gadolinium enhancement, Ventricle, medicine.anatomical_structure, business.industry, business, lcsh:Medical physics. Medical radiology. Nuclear medicine, lcsh:R895-920

1. El-Abassi, R, Singhal, D and England, JD. Fabry's disease. J Neuro Sci. 2014; 344: 5-19. DOI: http://dx.doi. org/10.1016/j.jns.2014.06.029. PMid: 25106696.

2. Moon, JC, Sachdev, B, Elkington, AG, et al. Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Eur Heart J. 2003; 24: 2151-2155. DOI: j.ehj.2003.09.017. PMid: 14643276.

3. Moon, JC, Sheppard, M, Reed, E, et al. The histological basis of late gadolinium enhancement cardiovascular magnetic resonance in a patient with Anderson-Fabry disease. J Cardiovasc Magn Reson. 2006; 8: 479-482. DOI: 10976640600605002. PMid: 16755835.

4. Gange, CA, Link, MS and Maron, MS. Utility of cardiovascular magnetic resonance in the diagnosis of Anderson-Fabry disease. Circulation. 2009; 120: e96-e97. DOI: CIRCULATIONAHA.109.849828. PMid: 19786638.

5. De Cobelli, F, Esposito, A, Belloni, E, et al. Delayedenhanced cardiac MRI for differentiation of Fabry's disease from symmetric hypertrophic cardiomyopathy. AJR Am J Roentgenol. 2009; 192: W97-W102. DOI: PMid: 19234246.

6. Sado, DM, White, SK, Piechnik, SK, et al. Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping. Circ Cardiovasc Imaging. 2013; 6: 392-398. DOI: CIRCIMAGING.112.000070. PMid: 23564562. [OpenAIRE]

7. Imbriaco, M, Spinelli, L, Cuocolo, A, et al. MRI characterization of myocardial tissue in patients with Fabry's disease. AJR. 2007; 188: 850-853. DOI: http:// PMid: 17312078. [OpenAIRE]

Any information missing or wrong?Report an Issue